Rianlon (300596.SZ) traded flat 0 % during a 24 hours period ending at 11:55 PM Central Europe on Monday 26th. One Rianlon stock can currently be bought for about CNY 35.36 on popular exchanges. Current supply of Rianlon stocks is 229.5 mn. Rianlon has a current market capitalization of CNY 8.5 bn and approximately CNY 79.6 mn worth of Rianlon was traded on exchanges in the last 24 hours. Since last month end, Rianlon has traded -8.97 % down. Simple moving average of last 200 days is at CNY 42.11. The highest price of past 52 weeks was recorded at CNY 56.48 on 02/25/2026. 52 weeks low was at CNY 34.81 on 07/21/2026.

Here is how related stocks have performed in the past 24 hours:

  • Sihui Fuji Electronic Tech (300852.SZ) traded flat 0 % and now trades at CNY 57.83. Sihui Fuji Electronic Tech has a market capitalisation of CNY 10.2 bn. Current price/earnings ratio for Sihui Fuji Electronic Tech is 39.06. SIHUI FUJI ELECTRONIC TECH has reported a sharp rise in profitability, largely driven by increased demand for high‑performance printed circuit boards in the AI computing sector. The company’s earnings have accelerated, with the latest quarter showing a significant boost in net profit relative to revenue. This growth is attributed to a shift toward higher‑density, multi‑layer boards used in AI servers, data‑storage systems, and power supplies, which offer greater value per unit. SIHUI FUJI ELECTRONIC TECH has also expanded its production capacity through new investment projects aimed at meeting the rising requirements of AI‑related hardware. The firm’s strategic focus on high‑end product development and efficient supply‑chain management has positioned it to capture a larger share of the growing market, while it continues to manage cost pressures linked to key raw materials.

  • Zhejiang Wolwo Bio-pharmac (300357.SZ) traded flat 0 % and now trades at CNY 21. Current market capitalisation for Zhejiang Wolwo Bio-pharmac is CNY 10.2 bn. Current price/earnings ratio for Zhejiang Wolwo Bio-pharmac is 24.3. On the morning of October 26, 2026, several pharmaceutical companies listed in the Chinese market experienced notable gains. Shares of the company in question moved upward alongside a broader industry rally that saw other drug manufacturers and biotechnology firms posting significant increases. The market reaction reflected a positive sentiment around innovation‑focused pharmaceutical stocks, with multiple names in the sector recording gains of more than ten percent during the session. This movement was part of a wider trend in the Chinese market, as reported by financial news outlets covering the day’s trading activity.

  • Ping An Healthcare And Techn (1833.HK) traded down -0.63 % and now trades at HKD 5.49. Current market capitalisation for Ping An Healthcare And Techn is HKD 11.9 bn. Current price/earnings ratio for Ping An Healthcare And Techn is 22.51.

  • Guangdong Marubi Biotechno (603983.SS) traded flat 0 % and now trades at CNY 25.26. Current market capitalisation for Guangdong Marubi Biotechno is CNY 10.2 bn. Current price/earnings ratio for Guangdong Marubi Biotechno is 50.78.

  • Xizang Zhufeng (600338.SS) traded flat 0 % and now trades at CNY 11.05. Xizang Zhufeng has a market capitalisation of CNY 10.2 bn. Current price/earnings ratio for Xizang Zhufeng is 17.61.


About Rianlon

Rianlon Corporation is a material industry supplier based in Tianjin, China, that specializes in providing anti-aging additives and application technologies for the global polymeric materials industry. They offer primary and secondary antioxidants, UV absorbers, light stabilizers, and U-packs, which are used in various industries such as automotive parts, coatings, construction materials, packaging, electronics, household goods, films, and other industries.